EPISODE · Aug 3, 2022 · 12 MIN
Cocrystal Pharma Discusses Therapeutic Platform Applications and Progress with The Stock Day Podcast
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Cocrystal Pharma, Inc. (Nasdaq: COCP) (“the Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. CFO and co-interim CEO James (Jim) Martin joined Stock Day host Sever Copley. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
The Stock Day Podcast welcomed Cocrystal Pharma, Inc. (Nasdaq: COCP) (“the Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. CFO and co-interim CEO James (Jim) Martin joined Stock Day host Sever Copley. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
Cocrystal Pharma Discusses Therapeutic Platform Applications and Progress with The Stock Day Podcast
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m